Literature DB >> 12022961

Antidepressant-like effects of cytidine in the forced swim test in rats.

William A Carlezon1, Andrea M Pliakas, Aimee M Parow, Michael J Detke, Bruce M Cohen, Perry F Renshaw.   

Abstract

BACKGROUND: Altered brain phospholipid metabolism may be involved in the pathophysiology of cocaine dependence and mood disorders. Evidence suggests that citicoline, a rate-limiting metabolite for phospholipid synthesis, reduces cocaine craving in human addicts. Because antidepressants can reduce cocaine craving, we explored in rats the possibility that citicoline has antidepressant effects. We also tested the primary metabolites of citicoline, cytidine and choline.
METHODS: We examined if citicoline or metabolites alter immobility in the forced swim test. We used two scoring methods: latency to become immobile, a simple method that identifies antidepressants, and behavioral sampling, a complex method that differentiates antidepressants according to pharmacological mechanisms.
RESULTS: Over a range of doses, citicoline did not affect behavior in the forced swim test. At molar equivalent doses, cytidine dramatically decreased immobility, whereas choline tended to increase immobility. The effects of cytidine resemble those of desipramine, a standard tricyclic antidepressant. None of the treatments affected locomotor activity, and cytidine did not establish conditioned place preferences.
CONCLUSIONS: Citicoline does not have effects in the forced swim test, but its primary metabolites have opposing effects: cytidine has antidepressant-like actions, whereas choline has prodepressant-like actions. At antidepressant doses, cytidine lacks stimulant and rewarding properties. This is the first report of potential antidepressant effects of cytidine.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12022961     DOI: 10.1016/s0006-3223(01)01344-0

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  15 in total

1.  Blockade of kappa opioid receptors attenuates the development of depressive-like behaviors induced by cocaine withdrawal in rats.

Authors:  Elena Chartoff; Allison Sawyer; Anna Rachlin; Dave Potter; Andrea Pliakas; William A Carlezon
Journal:  Neuropharmacology       Date:  2011-06-29       Impact factor: 5.250

2.  Open-label uridine for treatment of depressed adolescents with bipolar disorder.

Authors:  Douglas G Kondo; Young-Hoon Sung; Tracy L Hellem; Kristen K Delmastro; Eun-Kee Jeong; Namkug Kim; Xianfeng Shi; Perry F Renshaw
Journal:  J Child Adolesc Psychopharmacol       Date:  2011-04-12       Impact factor: 2.576

3.  The hypothalamic neuropeptide melanin-concentrating hormone acts in the nucleus accumbens to modulate feeding behavior and forced-swim performance.

Authors:  Dan Georgescu; Robert M Sears; Jonathan D Hommel; Michel Barrot; Carlos A Bolaños; Donald J Marsh; Maria A Bednarek; James A Bibb; Eleftheria Maratos-Flier; Eric J Nestler; Ralph J DiLeone
Journal:  J Neurosci       Date:  2005-03-16       Impact factor: 6.167

Review 4.  Dynorphin, stress, and depression.

Authors:  Allison T Knoll; William A Carlezon
Journal:  Brain Res       Date:  2009-09-24       Impact factor: 3.252

Review 5.  Factors influencing behavior in the forced swim test.

Authors:  Olena V Bogdanova; Shami Kanekar; Kristen E D'Anci; Perry F Renshaw
Journal:  Physiol Behav       Date:  2013-05-14

6.  Desipramine reduces stress-activated dynorphin expression and CREB phosphorylation in NAc tissue.

Authors:  Elena H Chartoff; Maria Papadopoulou; Matt L MacDonald; Aram Parsegian; David Potter; Christine Konradi; William A Carlezon
Journal:  Mol Pharmacol       Date:  2008-12-23       Impact factor: 4.436

7.  The guinea pig forced swim test as a new behavioral despair model to characterize potential antidepressants.

Authors:  Karsten M Wicke; Andre Rex; Ana Jongen-Relo; Ilona Groth; Gerhard Gross
Journal:  Psychopharmacology (Berl)       Date:  2007-07-24       Impact factor: 4.530

8.  Juvenile rats in the forced-swim test model the human response to antidepressant treatment for pediatric depression.

Authors:  Abbey L Reed; H Kevin Happe; Frederick Petty; David B Bylund
Journal:  Psychopharmacology (Berl)       Date:  2008-01-08       Impact factor: 4.530

9.  Lovastatin potentiates the antidepressant efficacy of fluoxetine in rats.

Authors:  Perry F Renshaw; Aram Parsegian; C Kevin Yang; Aileen Novero; Sujung J Yoon; In Kyoon Lyoo; Bruce M Cohen; William A Carlezon
Journal:  Pharmacol Biochem Behav       Date:  2008-11-05       Impact factor: 3.533

10.  Atypical Antipsychotic Lumateperone Effects on the Adrenal Gland With Possible Beneficial Effect of Quercetin Co-administration.

Authors:  Hala El-Haroun; Suzy Fayez Ewida; Wael M Y Mohamed; Manar Ali Bashandy
Journal:  Front Physiol       Date:  2021-06-29       Impact factor: 4.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.